Question 1

What are the key details for the project “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”?

Accepted Answer

The project “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)” is an infrastructure initiative in the Power Transmission sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”?

Accepted Answer

The status recorded for “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”?

Accepted Answer

Taiyo maps the stakeholders of “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

What is the budget and commercial profile for the project “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”?

Accepted Answer

Taiyo normalizes the budget of “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)” to USD 3000000.

Question 5

Where can I verify the source and access all details for “Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=115713). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	This FOA, issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, invites Research Project Grant (R01) applications that propose to investigate the early origins of cystic fibrosis (CF) lung disease and the mechanisms involved in development and progression of pulmonary abnormalities in young children with this condition. Studies may explore novel strategies for detecting early lung disease in infants and young children with CF, including minimally invasive biomarkers and/or imaging approaches, and utilize these methods to elucidate the molecular and cellular mechanisms of early lung disease onset and progression. The ultimate goal is development of novel approaches for diagnosis, prevention, and treatment of early CF lung disease.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)

Project Information FAQ

Project Information